Dirk Bittermann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dirk Bittermann has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Aebele Barber Mink van der Molen
Department of Pediatric Plastic and Reconstructive Surgery (KE.04.140.5), Wilhelmina Children's Hospital, P.O. Box 85090, 3508 AB, Utrecht, the Netherlands
1 shared publication - Andrea L. J. Kortlever
Knowledge Institute of the Federation of Medical Specialists, 3528 BL Utrecht, The Netherlands
1 shared publication - Anne Marie Kuijpers-Jagtman
Universitas Gadjah Mada
1 shared publication - Chantal M. Mouës
Department of Plastic Surgery and Hand Surgery, Medical Centre Leeuwarden, Leeuwarden, the Netherlands
1 shared publication - Christl Vermeij-Keers
Department of Plastic, Reconstructive and Hand Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands
1 shared publication - Frank Bierenbroodspot
Department Maxillo Facial Surgery, Isala, 8025 AB Zwolle, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 20 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 4813
Clinical Practice Guidelines on the Treatment of Patients with Cleft Lip, Alveolus, and Palate: An Executive Summary
Significant treatment variation exists in the Netherlands between teams treating patients with cleft lip, alveolus, and/or palate, resulting in a confusing and undesirable situation for patients, parents, and practitioners. Therefore, to optimize cleft care, clinical practice guidelines (CPGs) were developed. The aim of this report is to describe CPG development, share the main recommendations, and indicate knowledge gaps regarding cleft care. Together with patients and parents, a multidisciplinary working group of representatives from all relevant disciplines assisted by two experienced epidemiologists identified the topics to be addressed in the CPGs. Searching the Medline, Embase, and Cochrane Library databases identified 5157 articles, 60 of which remained after applying inclusion and exclusion criteria. We rated the quality of the evidence from moderate to very low. The working group formulated 71 recommendations regarding genetic testing, feeding, lip and palate closure, hearing, hypernasality, bone grafting, orthodontics, psychosocial guidance, dentistry, osteotomy versus distraction, and rhinoplasty. The final CPGs were obtained after review by all stakeholders and allow cleft teams to base their treatment on current knowledge. With high-quality evidence lacking, the need for additional high-quality studies has become apparent.
- 20 October 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (21) , 4813
Open AccessClinical Practice Guidelines on the Treatment of Patients with Cleft Lip, Alveolus, and Palate: An Executive Summary
Significant treatment variation exists in the Netherlands between teams treating patients with cleft lip, alveolus, and/or palate, resulting in a confusing and undesirable situation for patients, parents, and practitioners. Therefore, to optimize cleft care, clinical practice guidelines (CPGs) were developed. The aim of this report is to describe CPG development, share the main recommendations, and indicate knowledge gaps regarding cleft care. Together with patients and parents, a multidisciplinary working group of representatives from all relevant disciplines assisted by two experienced epidemiologists identified the topics to be addressed in the CPGs. Searching the Medline, Embase, and Cochrane Library databases identified 5157 articles, 60 of which remained after applying inclusion and exclusion criteria. We rated the quality of the evidence from moderate to very low. The working group formulated 71 recommendations regarding genetic testing, feeding, lip and palate closure, hearing, hypernasality, bone grafting, orthodontics, psychosocial guidance, dentistry, osteotomy versus distraction, and rhinoplasty. The final CPGs were obtained after review by all stakeholders and allow cleft teams to base their treatment on current knowledge. With high-quality evidence lacking, the need for additional high-quality studies has become apparent.